Key takeaways:
Darzalex (daratumumab) is a monoclonal antibody used to treat multiple myeloma in adults. It’s given as an infusion into the vein. An under-the-skin version, called Darzalex Faspro (daratumumab / hyaluronidase), is also available.
Common Darzalex side effects include infusion-related reactions, low blood cell counts, and fatigue. Mild infections, diarrhea, and nerve pain are also possible. Your oncology team can help you manage side effects like these.
Although rare, more severe side effects from Darzalex are possible. These serious infusion reactions and infections may require immediate medical attention.
Save on related medications
Darzalex (daratumumab) is a medication that treats multiple myeloma (a type of blood cancer) in adults. In fact, Darzalex was the first monoclonal antibody to be FDA approved for this type of cancer.
You can receive Darzalex as an intravenous (IV) infusion. But it's also available as a subcutaneous (under the skin) injection called Darzalex Faspro (daratumumab / hyaluronidase).
Both forms of Darzalex attack myeloma cancer cells, but they can affect healthy cells, too. This can lead to side effects. Knowing about possible side effects can help keep you safe and allow you to get the most from your medication.
Darzalex side effects at a glance
Your oncology team is the best resource for learning about Darzalex side effects. But here are two lists you can use to get the conversation started with them.
Common Darzalex side effects include:
Upper respiratory tract infections
Infusion- or injection-related reactions
Low white blood cell counts
Low red blood cell counts
Low platelets
Fatigue
Weakness
Nausea
Diarrhea
Constipation
Nerve pain
Back pain
Cough
Fever
Swelling in feet and/or hands
Rare side effects of Darzalex include:
Severe infusion-related reactions
Serious infections
Heart problems (with Darzalex Faspro only)
Here, we'll dive deeper into seven notable Darzalex side effects. We’ll also walk through how to manage them and what to expect if you receive Darzalex versus Darzalex Faspro.
1. Infusion reactions
Darzalex commonly causes infusion-related reactions. This side effect is more likely during the first infusion and becomes less likely with the following infusions.
Infusion-related reactions are similar to an allergic reaction. Symptoms to be aware of include:
Fever
Cough
Chills
Stuffy nose
Trouble breathing
Nausea
Changes in blood pressure
Your care team should monitor you during and after your Darzalex infusions to keep an eye out for this side effect. But let them know right away if you’re having any of the above symptoms.
While rare, you may develop symptoms of an infusion-related reaction up to 48 hours after a treatment — known as a delayed infusion reaction. If you experience a fever, trouble breathing, or changes in your heart rate in the days after an infusion, seek emergency medical attention right away.
Managing infusion reactions
To lower your risk of infusion reactions, your oncology team will likely give you “premedications” before each infusion. A common combination is acetaminophen (Tylenol), diphenhydramine (Benadryl), and a corticosteroid. Montelukast (Singulair) is also recommended in some cases.
Your oncologist may also want you to take a corticosteroid, such as methylprednisolone or dexamethasone, for a couple of days after each infusion to help prevent a delayed infusion reaction.
To further lower your risk of an infusion-related reaction, your oncology team will administer your first few Darzalex infusions at a slower rate. If you tolerate your first few Darzalex infusions well, you can receive future infusions at a faster rate.
If you experience a mild or moderate infusion-related reaction, your oncologist will likely administer your Darzalex infusions at a slower rate moving forward. If you experience a severe infusion-related reaction, you may need to stop Darzalex permanently.
Good to know: Darzalex Faspro is given as an injection under the skin, rather than an infusion. So instead of infusion reactions, it can cause injection site reactions. Symptoms can include redness, pain, and minor bleeding where you inject the medication. Rotating injection sites and injecting Darzalex Faspro slowly can help reduce these issues.
2. Low blood cell counts
Darzalex can lower the number of red blood cells, white blood cells, or platelets in your body. Your oncologist should regularly monitor your blood cell counts while you're receiving Darzalex because of this.
Red blood cells carry oxygen in the blood. Low levels of red blood cells can lead to anemia, which can make you feel weak or more tired than usual.
White blood cells play a key role in fighting off infections. So low levels of white blood cells increase your risk of developing infections (discussed below). If your white blood cell counts become too low, your oncologist may recommend taking antibiotics or antiviral medications to help prevent certain bacterial or viral infections.
Platelets are important for blood clotting. When platelets are low, you’re at a higher risk of unwanted bleeding. Signs of low platelets include nosebleeds and bleeding and bruising more easily. If you notice bleeding that’s hard to stop or see blood in your urine or stool, contact your oncologist right away.
3. Infections
As mentioned, Darzalex can increase your risk of infections. Common examples include mild upper respiratory tract infections, such as the common cold. But more serious infections, such as the flu or pneumonia, are also possible.
To help protect yourself from getting an infection:
Wash your hands (or use hand sanitizer) often.
Try to avoid crowded places.
Stay away from other people who are sick.
Wash raw fruit and vegetables well before eating them.
Getting flu, pneumonia, and COVID-19 vaccines before you start Darzalex can also help protect you against these infections.
Let your oncologist know right away if you have a fever of 100.4℉ or higher at any point during Darzalex treatment. This may be a sign of an infection. Milder infections can usually be treated with over-the-counter (OTC) medications. But severe infections will likely require treatment with prescription medication, as well as a pause in your cancer treatment.
4. Diarrhea or constipation
Darzalex can affect your bowel movements, causing diarrhea or constipation.
If you have diarrhea while you’re receiving Darzalex, try to stay well hydrated by drinking plenty of fluids throughout the day. Avoid sugary drinks, though, because they can make diarrhea worse. You can also try an OTC diarrhea medication, such as loperamide (Imodium A-D), if needed.
For constipation, drink lots of fluids and try to eat a high-fiber diet full of fruits and vegetables. Physical exercise can also help get things moving. OTC medications for constipation — such as stool softeners, like docusate (Colace), and laxatives, like senna (Senokot, Ex-Lax) — can also help ease constipation when needed.
Good to know: In general, you should only take OTC diarrhea and constipation products short term. Long-term use requires approval from your oncology team. Be sure to let them know about any stool changes that don’t improve or get worse while you’re receiving Darzalex.
5. Nerve pain
Darzalex can sometimes cause nerve pain, also known as peripheral neuropathy. The pain is caused by nerve damage and can lead to symptoms such as tingling sensations and pain or numbness in your hands or feet.
One way to help manage nerve pain from Darzalex is by wearing shoes that aren’t too tight and protect your feet well. Avoid overly hot showers and exposure to cold temperatures, as extreme temperatures can make nerve pain worse. Also, keep your hands and feet covered in the cold.
If your nerve pain becomes excessive, speak with your oncologist. They may prescribe a medication such as gabapentin (Neurontin) or duloxetine (Cymbalta) to help manage it. Alternative therapies, such as physical therapy and acupuncture, may also help.
6. Fatigue
Feeling weak or low on energy is common with Darzalex.
To help manage fatigue from Darzalex, rest and take short naps when needed. You can also try gentle exercises, such as walking, to help boost your energy levels. If you feel very tired after your Darzalex treatments, it’s a good idea to have a caregiver or family member assist with driving, cooking, and other attention-oriented tasks.
Let your oncologist know if you feel too tired or weak to complete your normal daily activities. They can check for low blood cell counts or pain that may be contributing to fatigue and suggest a treatment if warranted.
7. Back pain
Back pain is another potentially bothersome Darzalex side effect. There are several possible causes:
It’s believed that your body releases inflammatory proteins in the body, which can contribute to back pain, as a reaction to Darzalex.
Back pain may be a symptom of an infection related to low white blood cell levels.
Infusion-related reactions can also contribute to back pain.
Back pain may also be caused by multiple myeloma itself.
Several medications can help relieve symptoms of back pain. Your oncologist can recommend one that is appropriate for you. You can also try nonmedication remedies. Some options include getting a massage, applying heat or ice to the area, and seeing a chiropractor for spinal manipulation.
Do Darzalex and Darzalex Faspro cause the same side effects?
Darzalex and Darzalex Faspro both contain daratumumab. But they have a few differences. The main distinction is that Darzalex Faspro contains an enzyme (protein) called hyaluronidase. This allows daratumumab to be given as an injection under the skin rather than as an IV infusion.
Darzalex Faspro has similar side effects to traditional Darzalex infusions. But it can cause injection-related reactions instead of infusion-related reactions. Symptoms of an injection-related reaction include redness and swelling at the injection site. Injection reactions are more common with your first Darzalex Faspro injection, but they should get better over time.
Unlike Darzalex, Darzalex Faspro is also approved to treat a condition called light chain amyloidosis. Some people who have received Darzalex Faspro for amyloidosis have experienced serious heart problems, such as heart failure. If you have a history of heart problems, you may be at a higher risk of this side effect.
Frequently asked questions
It depends. Some Darzelex side effects, such as infusion reactions and nausea, typically resolve on their own within a few days of an infusion. Others, such as low blood cell counts and fatigue, may worsen over time.
Your oncology team should check in about how you’ve been feeling before each Darzelex infusion. This is to keep an eye out for any side effects that are affecting your daily life and, if needed, take steps to manage them. Be sure to communicate openly and honestly with them about how you’re feeling throughout your treatment.
Darzalex stays in your system for quite some time after you receive an infusion. It can take 90 days or longer to fully clear it from your body after your last dose.
No, Darzalex is not the same as chemotherapy. Darzalex treats cancer, but it works differently than traditional chemo. Darzalex is a monoclonal antibody that’s designed to bind to a specific protein found on the surface of multiple myeloma cells. It’s a targeted treatment that specifically works for this type of cancer.
It depends. Some Darzelex side effects, such as infusion reactions and nausea, typically resolve on their own within a few days of an infusion. Others, such as low blood cell counts and fatigue, may worsen over time.
Your oncology team should check in about how you’ve been feeling before each Darzelex infusion. This is to keep an eye out for any side effects that are affecting your daily life and, if needed, take steps to manage them. Be sure to communicate openly and honestly with them about how you’re feeling throughout your treatment.
Darzalex stays in your system for quite some time after you receive an infusion. It can take 90 days or longer to fully clear it from your body after your last dose.
No, Darzalex is not the same as chemotherapy. Darzalex treats cancer, but it works differently than traditional chemo. Darzalex is a monoclonal antibody that’s designed to bind to a specific protein found on the surface of multiple myeloma cells. It’s a targeted treatment that specifically works for this type of cancer.
The bottom line
Common Darzalex (daratumumab) side effects include infusion-related reactions, low blood cell counts, and infections. Fatigue, diarrhea, and nerve pain are also possible. More severe Darzalex side effects, such as serious infusion reactions and serious infections, can also happen.
Darzalex and Darzalex Faspro (daratumumab / hyaluronidase) cause similar side effects. But Darzalex Faspro carries an additional risk of heart problems for those receiving it to treat amyloidosis. And it can cause injection site reactions rather than infusion reactions.
Talk to your oncologist or pharmacist if you have questions or concerns about potential Darzalex side effects.
Why trust our experts?



References
American Association for Cancer Research. (n.d.). An immunotherapeutic for multiple myeloma.
Centers for Disease Control and Prevention. (2025). Preventing infections that can lead to sepsis.
International Myeloma Foundation. (2026). Darzalex (daratumumab).
Janssen Biotech. (2025). Darzalex - daratumumab injection, solution, concentrate, Darzalex IV - daratumumab injection, solution, concentrate [package insert].
Janssen Biotech. (2026). Darzalex Faspro - daratumumab and hyaluronidase-fihj (human recombinant) injection [package insert].
MedlinePlus. (2024). White blood count (WBC).
MedlinePlus. (2025). Anemia.
MedlinePlus. (2025). Platelet count.
Mo, B., et al. (2025). Unmasking multiple myeloma: The importance of suspecting malignancy in atypical chronic pain mimicking degenerative conditions — A case report. Clinical Case Reports.
Sanchez, L., et al. (2016). Daratumumab: A first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma. Journal of Hematology & Oncology.
